Hanmi Science has been granted a patent for a novel glucagon derivative peptide, which demonstrates enhanced activation of glucagon-like peptide-1 and glucagon receptors. This peptide is proposed as an effective treatment for obesity, with its specific amino acid sequence detailed in the patent claim. GlobalData’s report on Hanmi Science gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on Hanmi Science, Hormone-based therapies for metabolic disorders was a key innovation area identified from patents. Hanmi Science's grant share as of July 2024 was 41%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent US12018060B2 outlines a novel peptide characterized by the amino acid sequence identified as SEQ ID NO: 14. This peptide is notable for its ability to activate both the GLP-1 receptor and the glucagon receptor, which are critical in metabolic regulation. Additionally, the peptide demonstrates an anti-obesity effect, making it a potential therapeutic agent for weight management. The claims further specify that the peptide may contain structural features, such as at least one amino acid pair forming a ring at designated positions, which could enhance its biological activity.
The patent also encompasses a pharmaceutical composition that includes the peptide as an active ingredient, potentially combined with a pharmaceutically acceptable carrier. This composition can be administered alone or in conjunction with other obesity-treating pharmaceutical formulations, such as GLP-1 receptor agonists, leptin receptor agonists, and various receptor antagonists and agonists that target metabolic pathways. The claims detail methods for treating obesity by administering either the peptide or the pharmaceutical composition to individuals in need, highlighting its therapeutic applications in obesity management.
To know more about GlobalData’s detailed insights on Hanmi Science, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.